Skip to main content
. 2012 Sep 12;2012(9):CD001781. doi: 10.1002/14651858.CD001781.pub3

Wu 2005.

Study characteristics
Methods This study was carried out in a secondary care setting.
The blinding within this study was unclear.
It was unclear if ITT analysis was carried out
This study was conducted in China.
Participants 60 participants were recruited: None dropped out.
Inclusion criteria of the trial
  • Adults

  • Ordinary or refractory warts not specified

  • Warts on the hands and face

Interventions
  • Chinese tradition herbal medicine (Qu You Ding)

  • Peptide butylamine lineament in the control group


Both groups underwent a 2‐week course of daily treatment.
Outcomes Outcomes of the trial
  1. Cure at 8 weeks

Notes The article was in Chinese; full translation was obtained.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk The method of randomisation was unclear.
Allocation concealment (selection bias) Unclear risk Allocation concealment was unclear.
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk No details were given about blinding.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No details were given about blinding.
Incomplete outcome data (attrition bias)
All outcomes High risk 6/60 participants were not included in the analysis because of incomplete data: 2/30 participants were in the treatment group; 4/30 participants were in the control group.
It was unclear why the participants discontinued.
Selective reporting (reporting bias) Low risk All outcomes were reported.